Maxigen Biotech Inc. (TPE:1783)
Taiwan · Delayed Price · Currency is TWD 39.80
-0.05 (-0.13%)
Jul 30, 2026, 1:30 PM CST
Maxigen Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 825.25 | 811.56 | 680.65 | 622.12 | 604.43 | 511.98 |
Revenue Growth | 12.93% | 19.23% | 9.41% | 2.93% | 18.06% | 11.86% |
Gross Profit Gross Profit Growth | 573.04 | 563.72 | 483.33 | 424.09 | 373.99 | 261.03 |
Operating Income Operating Income Growth | 267.42 | 261.04 | 179.91 | 149.85 | 128.62 | 89.95 |
Net Income Net Income Growth | 271.02 | 265.31 | 190.17 | 165.83 | 139.4 | 87.67 |
Earnings Per Share EPS Growth | 3.00 | 2.94 | 2.12 | 1.85 | 1.56 | 1.04 |
EPS Growth | 29.50% | 38.68% | 14.59% | 18.59% | 50.28% | 31.75% |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Taiwan Taiwan Growth | 322.95 | 303.33 |
Asia Asia Growth | 154.27 | 121.78 |
Europe and America Europe and America Growth | 328.86 | 255.54 |
Other Regions Other Regions Growth | 5.48 | - |
Total Total Growth | 811.56 | 680.65 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 949.53 | 876.19 | 639.05 | 431.08 | 799.76 | 527.15 |
Total Debt Total Debt Growth | 100 | 100 | - | - | - | 9.64 |
Net Cash (Debt) Net Cash Growth | 849.53 | 776.19 | 639.05 | 431.08 | 799.76 | 517.51 |
Net Cash Growth | 20.86% | 21.46% | 48.24% | -46.10% | 54.54% | 161.86% |
Net Cash Per Share Net Cash Per Share Growth | 9.40 | 8.59 | 7.12 | 4.82 | 8.95 | 6.12 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 294.91 | 290.22 | 298.22 | 171.2 | 268.34 | 117.59 |
Capital Expenditures CapEx Growth | -84.07 | -81.87 | -31.77 | -22.44 | -14.29 | -14.26 |
Free Cash Flow Free Cash Flow Growth | 210.84 | 208.36 | 266.45 | 148.76 | 254.05 | 103.34 |
Free Cash Flow Growth | -26.65% | -21.80% | 79.12% | -41.44% | 145.85% | 61.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 69.44% | 69.46% | 71.01% | 68.17% | 61.88% | 50.98% |
Operating Margin | 32.41% | 32.16% | 26.43% | 24.09% | 21.28% | 17.57% |
Pretax Margin | 38.02% | 37.57% | 33.14% | 31.05% | 27.43% | 19.04% |
Profit Margin | 32.84% | 32.69% | 27.94% | 26.66% | 23.06% | 17.12% |
FCF Margin | 25.55% | 25.67% | 39.15% | 23.91% | 42.03% | 20.18% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 0.830 | 1.000 | 0.476 |
Dividend Per Share Growth | 140.93% | 140.96% | -17.00% | 110.00% | - |
Dividend Yield | 4.99% | 4.67% | 1.73% | 2.15% | 1.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.28 | 14.47 | 22.95 | 25.96 | 28.95 | 45.59 |
Forward PE | - | 10.53 | 10.53 | 10.53 | 10.53 | 10.53 |
P/FCF Ratio | 16.95 | 18.42 | 16.38 | 28.94 | 15.89 | 38.67 |
PS Ratio | 4.33 | 4.73 | 6.41 | 6.92 | 6.68 | 7.81 |